AAAAAA
Results:
1-13
|
Results: 13
Authors:
Taylor, DO
Barr, ML
Meiser, BM
Pham, SM
Mentzer, RM
Gass, AL
Citation: Do. Taylor et al., Suggested guidelines for the use of tacrolimus in cardiac transplant recipients, J HEART LUN, 20(7), 2001, pp. 734-738
Authors:
Weis, M
Pehlivanli, S
Meiser, BM
von Scheidt, W
Citation: M. Weis et al., Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation, J AM COL C, 38(3), 2001, pp. 814-818
Authors:
Groetzner, J
Meiser, BM
Schirmer, J
Koglin, J
Scheidt, W
Klauss, W
Cremer, P
Reichenspurner, H
Reichart, B
Citation: J. Groetzner et al., Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: Which treatment reveals more side effects during long-term follow-up?, TRANSPLAN P, 33(1-2), 2001, pp. 1461-1464
Authors:
Treede, H
Reichenspurner, H
Meiser, BM
Kur, F
Furst, H
Vogelmeier, C
Briegel, J
Reichart, B
Citation: H. Treede et al., Incidence and spectrum of infections in lung transplanted patients: Comparison of four different immunosuppressive protocols, TRANSPLAN P, 33(1-2), 2001, pp. 1620-1621
Authors:
Weis, M
Wildhirt, SM
Schulze, C
Pehlivanli, S
Rieder, S
Wolf, WP
Wilbert-Lampen, U
Meiser, BM
Enders, G
von Scheidt, W
Citation: M. Weis et al., Coronary vasomotor dysfunction in the cardiac allograft: Impact of different immunosuppressive regimens, J CARDIO PH, 36(6), 2000, pp. 776-784
Authors:
Meiser, BM
Pfeiffer, M
Schmidt, D
Reichenspurner, H
Ueberfuhr, P
Paulus, D
von Scheidt, W
Kreuzer, E
Seidel, D
Reichart, B
Citation: Bm. Meiser et al., Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: Importance of mycophenolic acid therapeutic drug monitoring, J HEART LUN, 18(2), 1999, pp. 143-149
Authors:
Weis, M
Wildhirt, SM
Schulze, C
Rieder, G
Wilbert-Lampen, U
Wolf, WP
Arendt, RM
Enders, G
Meiser, BM
von Scheidt, W
Citation: M. Weis et al., Endothelin in coronary endothelial dysfunction early after human heart transplantation, J HEART LUN, 18(11), 1999, pp. 1071-1079
Authors:
Kur, F
Reichenspurner, H
Meiser, BM
Welz, A
Furst, H
Muller, C
Vogelmeier, C
Schwaiblmaier, M
Briegel, J
Reichart, B
Citation: F. Kur et al., Tacrolismus (FK506) as primary immunosuppressant after lung transplantation, THOR CARD S, 47(3), 1999, pp. 174-178
Authors:
Meiser, BM
Pfeiffer, M
Schmidt, D
Ueberfuhr, P
Reichenspurner, H
Paulus, D
von Scheidt, W
Kreuzer, E
Seidel, D
Reichart, B
Citation: Bm. Meiser et al., The efficacy of the combination of tacrolimus and mycophenolate mofetil for prevention of acute myocardial rejection is dependent on routine monitoring of mycophenolic acid trough acid levels, TRANSPLAN P, 31(1-2), 1999, pp. 84-87
Authors:
Reichenspurner, H
Kur, F
Treede, H
Meiser, BM
Welz, A
Vogelmeier, C
Schwaiblmeier, M
Muller, C
Furst, H
Briegel, J
Reichart, B
Citation: H. Reichenspurner et al., Tacrolimus-based immunosuppressive protocols in lung transplantation, TRANSPLAN P, 31(1-2), 1999, pp. 171-172
Authors:
Weis, M
Wildhirt, SM
Schulze, C
Pehlivanli, S
Fraunberger, P
Meiser, BM
von Scheidt, W
Citation: M. Weis et al., Modulation of coronary vasomotor tone by cytokines in cardiac transplant recipients, TRANSPLANT, 68(9), 1999, pp. 1263-1267
Authors:
Reichenspurner, H
Kur, F
Treede, H
Meiser, BM
Deutsch, O
Welz, A
Vogelmeier, C
Schwaiblmair, M
Muller, C
Furst, H
Briegel, J
Reichart, B
Citation: H. Reichenspurner et al., Optimization of the immunosuppressive protocol after lung transplantation, TRANSPLANT, 68(1), 1999, pp. 67-71
Authors:
Barr, ML
Meiser, BM
Eisen, HJ
Roberts, RF
Livi, U
Dall'Amico, R
Dorent, R
Rogers, JG
Radovancevic, B
Taylor, DO
Jeevanandam, V
Marboe, CC
Franco, EL
Ventura, HO
Michler, RE
Griffith, BP
Boyce, SW
Reichart, B
Gandjbakhch, I
Citation: Ml. Barr et al., Photopheresis for the prevention of rejection in cardiac transplantation, N ENG J MED, 339(24), 1998, pp. 1744-1751
Risultati:
1-13
|